RBC Bearings Inc
Machinery
RBC Bearings Inc (RBC) Stock News
The latest RBC headlines and market coverage — 4 recent stories, updated throughout the day.
- Benzinga·Neutral
RBC Global Asset Management Inc. announces RBC ETF cash distributions for May 2026
RBC Global Asset Management Inc. announced May 2026 cash distributions for unitholders of RBC ETFs across various bond, equity, and dividend-focused funds. Unitholders of record on May 22, 2026, will receive distributions payable on May 29, 2026.
- GlobeNewswire Inc.·
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
Sionna Therapeutics, a clinical-stage biopharmaceutical company focused on cystic fibrosis treatment, announced that management will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on May 20th, 2026. The company is developing novel medicines targeting the CFTR protein, with a focus on NBD1 stabilizers to address the F508del genetic mutation.
- GlobeNewswire Inc.·
Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference
Opus Genetics, a clinical-stage biopharmaceutical company developing gene therapies for inherited retinal diseases, announced that management will present at the RBC Capital Markets 2026 Global Healthcare Conference on May 19, 2026. The company is advancing its pipeline of seven AAV-based programs, with lead candidates OPGx-LCA5 and OPGx-BEST1.
- GlobeNewswire Inc.·
Cytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
Cytokinetics announced that its management team will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on May 19, 2026. The company will discuss its cardiovascular biopharmaceutical pipeline, including MYQORZO® (aficamten) for obstructive hypertrophic cardiomyopathy and ongoing development of omecamtiv mecarbil and ulacamten for heart failure treatments.